<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(1)</volume><submitter>Xiong C</submitter><pubmed_abstract>Dysfunctions of ATP-binding cassette, subfamily D, member 1 (ABCD1) cause X-linked adrenoleukodystrophy, a rare neurodegenerative disease that affects all human tissues. Residing in the peroxisome membrane, ABCD1 plays a role in the translocation of very long-chain fatty acids for their β-oxidation. Here, the six cryo-electron microscopy structures of ABCD1 in four distinct conformational states were presented. In the transporter dimer, two transmembrane domains form the substrate translocation pathway, and two nucleotide-binding domains form the ATP-binding site that binds and hydrolyzes ATP. The ABCD1 structures provide a starting point for elucidating the substrate recognition and translocation mechanism of ABCD1. Each of the four inward-facing structures of ABCD1 has a vestibule that opens to the cytosol with variable sizes. Hexacosanoic acid (C26:0)-CoA substrate binds to the transmembrane domains (TMDs) and stimulates the ATPase activity of the nucleotide-binding domains (NBDs). W339 from the transmembrane helix 5 (TM5) is essential for binding substrate and stimulating ATP hydrolysis by substrate. ABCD1 has a unique C-terminal coiled-coil domain that negatively modulates the ATPase activity of the NBDs. Furthermore, the structure of ABCD1 in the outward-facing state indicates that ATP molecules pull the two NBDs together and open the TMDs to the peroxisomal lumen for substrate release. The five structures provide a view of the substrate transport cycle and mechanistic implication for disease-causing mutations.</pubmed_abstract><journal>Signal transduction and targeted therapy</journal><pagination>74</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9944889</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Structural insights into substrate recognition and translocation of human peroxisomal ABC transporter ALDP.</pubmed_title><pmcid>PMC9944889</pmcid><pubmed_authors>Wang TH</pubmed_authors><pubmed_authors>Wu XT</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Tang L</pubmed_authors><pubmed_authors>Xiong LL</pubmed_authors><pubmed_authors>Hong Z</pubmed_authors><pubmed_authors>Xiong WX</pubmed_authors><pubmed_authors>Zhou D</pubmed_authors><pubmed_authors>Xiong C</pubmed_authors><pubmed_authors>Jia LN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structural insights into substrate recognition and translocation of human peroxisomal ABC transporter ALDP.</name><description>Dysfunctions of ATP-binding cassette, subfamily D, member 1 (ABCD1) cause X-linked adrenoleukodystrophy, a rare neurodegenerative disease that affects all human tissues. Residing in the peroxisome membrane, ABCD1 plays a role in the translocation of very long-chain fatty acids for their β-oxidation. Here, the six cryo-electron microscopy structures of ABCD1 in four distinct conformational states were presented. In the transporter dimer, two transmembrane domains form the substrate translocation pathway, and two nucleotide-binding domains form the ATP-binding site that binds and hydrolyzes ATP. The ABCD1 structures provide a starting point for elucidating the substrate recognition and translocation mechanism of ABCD1. Each of the four inward-facing structures of ABCD1 has a vestibule that opens to the cytosol with variable sizes. Hexacosanoic acid (C26:0)-CoA substrate binds to the transmembrane domains (TMDs) and stimulates the ATPase activity of the nucleotide-binding domains (NBDs). W339 from the transmembrane helix 5 (TM5) is essential for binding substrate and stimulating ATP hydrolysis by substrate. ABCD1 has a unique C-terminal coiled-coil domain that negatively modulates the ATPase activity of the NBDs. Furthermore, the structure of ABCD1 in the outward-facing state indicates that ATP molecules pull the two NBDs together and open the TMDs to the peroxisomal lumen for substrate release. The five structures provide a view of the substrate transport cycle and mechanistic implication for disease-causing mutations.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-04T22:39:12.184Z</modification><creation>2025-04-04T22:39:12.184Z</creation></dates><accession>S-EPMC9944889</accession><cross_references><pubmed>36810450</pubmed><doi>10.1038/s41392-022-01280-9</doi></cross_references></HashMap>